Measured Wealth Private Client Group, LLC - PROTALIX BIOTHERAPEUTICS INC ownership

PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A101. A total of 1 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Measured Wealth Private Client Group, LLC ownership history of PROTALIX BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2019$8,000
-55.6%
38,1160.0%0.01%
-50.0%
Q2 2019$18,000
+5.9%
38,1160.0%0.01%0.0%
Q1 2019$17,00038,1160.01%
Other shareholders
PROTALIX BIOTHERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 1,178,440$5,397,0004.64%
GREAT POINT PARTNERS LLC 912,155$4,178,0002.18%
Camber Capital Management LP 2,000,000$9,160,0000.72%
Mivtachim The Workers Social Insurance Fund Ltd. (Under Special Management) 703,443$3,222,0000.34%
MENORA MIVTACHIM HOLDINGS LTD. 836,078$3,829,0000.31%
FEDERATED HERMES, INC. 10,240,014$46,900,0000.16%
DELTEC ASSET MANAGEMENT LLC 109,473$501,0000.11%
Baillie Gifford 5,882,224$26,941,0000.06%
Allianz Asset Management GmbH 7,480,712$34,262,0000.04%
NJ State Employees Deferred Compensation Plan 40,000$183,0000.04%
View complete list of PROTALIX BIOTHERAPEUTICS INC shareholders